CRISPR Gene Editing: Breaking Barriers for Rare Disease Treatment
June 12, 2026
Rare diseases, with low incidence and complex pathogenesis, have long been known as “intractable diseases” in medicine. Most rare diseases
Global Pharma Trends
Designed for medical practitioners, industry researchers, and healthcare professionals, this series bridges the gap between cutting-edge medical research and real-world clinical application. It systematically interprets innovative treatment technologies, updated medical guidelines, breakthrough drug developments, and transformative healthcare models, helping readers quickly grasp evolving medical frontiers.
Latest News
Health Equity: The Core Trend of Global Medical Development in 2026
June 12, 2026
Global medical development is undergoing a profound structural change in 2026, with health equity officially moving from a marginal social
Gut Microbiome: The Hidden Regulator of Human Health and Disease
June 12, 2026
The human gut microbiome, known as the “second genome”, plays a core regulatory role in human metabolism, immunity, nervous system
How Generative AI Is Reshaping Modern Clinical Practice
Artificial intelligence has evolved from an experimental medical tool to a core clinical assistant in 2026, with generative AI leading
June 12, 2026
CRISPR Gene Editing: Breaking Barriers for Rare Disease Treatment
Rare diseases, with low incidence and complex pathogenesis, have long been known as “intractable diseases” in medicine. Most rare diseases
June 12, 2026